Učitavanje...
Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinoma
Thymic carcinoma is an uncommon neoplasm. The efficacy of second-line treatment with docetaxel in advanced thymic carcinoma has not been well studied. Therefore, we conducted a review of the efficacy of docetaxel-based chemotherapy as a second-line regimen for advanced thymic carcinoma. Fifteen pati...
Spremljeno u:
| Izdano u: | Thorac Cancer |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BlackWell Publishing Ltd
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704314/ https://ncbi.nlm.nih.gov/pubmed/26766995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12064 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|